Wa

OTC products · Product label record

Wart Remover drug information

SALICYLIC ACID
Guangzhou Hechuang Commercial Service Co.,Ltd. · TOPICAL

Product NDC: 87298-053

Join the community
CommunityExperiencesReviewsDrug database
Source label information, not individualized medical advice. This record applies to the product and labeler shown below. Compare the exact formulation, strength and country with your package and the current source label.
Generic nameSALICYLIC ACID
Labeler / manufacturerGuangzhou Hechuang Commercial Service Co.,Ltd.
RouteTOPICAL
Drug classDrug class not supplied in source label
Product NDC87298-053
Label effective date2026-08-18

Official product label reference

Wart Remover — Guangzhou Hechuang Commercial Service Co.,Ltd.

This page contains 11 source sections for SALICYLIC ACID, topical route. Label set 594ecfe5-8d9d-be3b-e063-6294a90a5f2e, version 1.

Retrieved 2026-10-02 · openFDA dataset updated 2026-10-02 · Check the current DailyMed label

Label records can cover multiple strengths or package sizes. A label listing does not by itself establish FDA approval or current market availability. Check the source and application history for this specific product.

Uses described in the label

Uses • for the removal of common and plantar warts

Purpose

Purpose Wart remover
Dosage and administration — label text
Directions Directions • Wash the affected area. • You may soak the wart in warm water for about 5 minutes. • Dry the area thoroughly. • Apply a small amount to sufficiently cover each wart using the precision brush or a dual-tip cotton swab. • Allow to dry completely. • Repeat once or twice daily as directed until the wart is removed, for up to 12 weeks.
Warnings
Warnings Warnings • For external use only. • Keep away from fire or flame. Do not use • on irritated, infected, or reddened skin • on moles, birthmarks, warts with hair growing from them,or genital warts • on warts on the face or mucous membranes • if you have diabetes or poor blood circulation When using this product • avoid contact with eyes • if product gets into the eyes, flush with water for 15 minutes • avoid contact with surrounding healthy skin • avoid inhaling vapors
Active ingredient
Active Ingredient Salicylic acid 17%
When to stop use and seek help
Stop use and ask a doctor if Stop use and ask a doctor if • excessive irritation occurs • discomfort persists • the condition worsens
Child safety
Keep out of reach of children Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Other safety information
Other Information • Cap bottle tightly after each use. • Store at room temperature away from heat.
Inactive ingredient
Inactive Ingredients Glycerin, Laurocapram, Nitrocellulose, Poliglusam,Polyvinyl Alcohol, Purified Water
Product description
MAXIMUM STRENGTH √ QUICK-DRY FILM √ PRECISION BRUSH √ TARGETED WART REMOVAL INCLUDES 10 DUAL-TIP COTTON SWABS QUICK-DRY FILM FORMULA Designed for targeted removal of common and plantar warts. PRECISION APPLICATION Brush directly onto the wart for controlled application. DRYING FILM Dries to form a thin film over the treated area. TWO WAYS TO APPLY Precision Brush 10 Dual-Tip Cotton Swabs TARGETED EASY APPLICATION LESS MESS INCLUDES: 1 × 30 mL Wart Remover 10 × Dual-Tip Cotton Swabs 1 × Instruction Leaflet Made in China
Unclassified section
Distributor: Wenzhou Yuyuan Pharmaceutical Co., Ltd. Address: The first room on the west side of Suite 510, Oushang Building, No. 1119 Ouhai Avenue, Louggiao Subdistrict, Ouhai District, Zhejiang 325600, China

Official sources and product identifiers

Substances listed: SALICYLIC ACID

RxNorm identifiers: 312881

Package NDC codes

87298-053-01

Further research and background

These are external searches for related information. Research, encyclopedia and news articles have not been imported into this product record.

Coverage and corrections

The text is extracted from a US structured product label. Tables are represented as text where supplied; formatting and illustrations may be lost. A missing section does not mean a risk is absent. This reference has not been independently reviewed by a clinician and is not a live safety-alert service.

Source retrieved 2026-10-02. Read the source policy.